2-chloro-n(6)cyclopentyladenosine has been researched along with fluo-3 in 1 studies
| Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (fluo-3) | Trials (fluo-3) | Recent Studies (post-2010) (fluo-3) |
|---|---|---|---|---|---|
| 252 | 0 | 43 | 759 | 1 | 108 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lasley, RD; Mentzer, RM; Narayan, P | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and fluo-3
| Article | Year |
|---|---|
Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes.
Topics: Adenosine; Aniline Compounds; Animals; Calcium; Decanoic Acids; Drug Synergism; Fluoresceins; Fluorescent Dyes; Glyburide; Heart Ventricles; Hydroxy Acids; Ion Transport; Male; Microscopy, Fluorescence; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Oxidation-Reduction; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Purinergic P1; Xanthenes; Xanthines | 2001 |